Long-Term Efficacy, Safety, and Tolerability of Rilpivirine (RPV, TMC278) in HIV Type 1-Infected Antiretroviral-Naive Patients: Week 192 Results from a Phase IIb Randomized Trial
2012 ◽
Vol 28
(5)
◽
pp. 437-446
◽
Keyword(s):
2013 ◽
Vol 29
(3)
◽
pp. 564-573
◽
2008 ◽
Vol 24
(6)
◽
pp. 753-760
◽
Keyword(s):
2001 ◽
Vol 17
(13)
◽
pp. 1265-1271
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 19
(2)
◽
pp. 109-114
◽
Keyword(s):
2020 ◽
Vol 22
(9)
◽
pp. 1516-1526
◽